Ligne de temps

Camille Chauvin
Post-doctorant(e)
03 févr. 2023
publication

Tocilizumab treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants.

Lire plus
09 oct. 2020
project

Study of immune crosstalk in COVID-19 COVIMUNE

Lire plus